Rezon Bio offers an integrated gene-to-IND development pathway designed to deliver tox and Phase I material for early-stage NBE programs and enables fast commercial readiness. The approach combines our efficient and proven platform approaches, with high-throughput process development, direct scale-up strategies that skip intermediate bioreactor steps where scientifically justified, and seamless coordination between drug substance and drug product services via qualified external partners. Transparent, milestone-based pricing and dedicated project management keep programs on timeline and within defined cost parameters from day one. Early-stage teams work with a single experienced partner across the full pre-IND journey rather than managing handoffs between vendors at a stage where timeline compression is a competitive necessity.
Q: How efficiently can Rezon Bio take an NBE from gene to IND?
Read more
Where innovation meets execution
- Whether you’re advancing a novel biologic or planning for commercial scale, Rezon Bio is ready to help you move forward with confidence.
- Connect with our team to explore how our expertise, integrated solutions, and dedication can accelerate your success.